weight loss drugs have a cost problem.

Item request has been placed! ×
Item request cannot be made. ×
loading   Processing Request
Read Online Read More Add to Saved list
  • Additional Information
    • Subject Terms:
      UNITED States
    • Abstract:
      The article discusses issues concerning the high cost of weight loss drugs in the U.S. Topics explored include outlook for the use of glucagon-like peptide 1 (GLP-1) receptor agonists to treat diabetes and obesity, the lack of private health insurance coverage for obesity medications, and the proposed Treat and Reduce Obesity Act which aims to expand Medicare coverage to include weight loss drugs.